Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides

Journal of the American Society for Mass Spectrometry

Volumn 15, Issue 4, 2004, Pages 496-509

  Lapolla, Annunziata ^a   Fedele, Domenico ^a   Reitano, Rachele ^a   Aricò, Nadia Concetta ^a   Seraglia, Roberta ^b   Traldi, Pietro ^b,d   Marotta, Ester ^a   Tonani, Roberto ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c PFIZER INC   (United States)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MATHEMATICAL MODELS; MIXTURES; MOLECULAR DYNAMICS; PATIENT TREATMENT; SOLVENTS;

ENZYMATIC DIGESTION; MOLECULAR MODELING;

ENZYMES;

ADVANCED GLYCATION END PRODUCT; AMIDE; HUMAN SERUM ALBUMIN; PROTEINASE; TRYPSIN;

MASS SPECTROMETRY;

ARTICLE; DIABETES MELLITUS; HUMAN; KIDNEY DISEASE; MASS SPECTROMETRY; MOLECULAR MODEL; PEPTIDE ANALYSIS; PROTEIN DATABASE; PROTEIN GLYCOSYLATION; TANDEM MASS SPECTROMETRY;

EID: 1642544549     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2003.11.014     Document Type: Article

References (24)

1. Maillard L.C. Action des acides aminés sur le sucres formation des mélanoidines per voie méthodique. C. R. Acad. Sci. 154:1912;66-68.
2. Vlassara H., Bucala R., Stiker L. Pathogenic Effects of Advanced Glycosylation Biochemical, Biologic, and Clinical Implication for Diabetes and Aging. Lab. Invest. 70:1991;138-151.
3. Lyons T.J., Jenkins A. Glycation, Oxidation, and Lipooxidation in the Development of the Complications of Diabetes A Carbonyl Stress Hypothesis. I. Diab. Rev. 5:1997;365-391.
4. Thornalley P.J. The Clinical Significance of Glycation. Clin. Lab. 45:1999;263-273.
5. Brownlee M., Vlassara H., Cerami A. Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications. Ann. Intern. Med. 101:1984;527-537.
6. Brownlee M. Lilly Lecture 1993. Glycation and Diabetic Complications. Diabetes. 43:1994;836-841.
7. Bucala R., Makita Z., Vaga G., Grundy S., Kshinsky T., Cerami A., Vlassara H. Modification of Low Density Lipoprotein by Advanced Glycation End Products Contributes to Dyslipidemia of Diabetes and Renal Insufficiency. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9441-9445.
8. Gugliucci A., Menini T. Circulating Advanced Glycation Peptides in Streptozotocin-Induced Diabetic Rats Evidence for Preferential Modification of IgG Light Chains. Life Sci. 62:1998;2141-2150.
9. Horiuchi S., Higashi T., Ikeda K., Saishoji T., Jinnouchi Y., Sano H., Shibayama R., Sakamoto T., Araki N. Advanced Glycation End Products and Their Recognition by Macrophage and Macrophage-Derived Cells. Diabetes. 45:1996;S73-S76.
10. Dean R.T. Lysosomal Enzymes as Agents of Turnover of Soluble Cytoplasmatic Proteins. Eur. J. Biochem. 58:1975;9-14.
11. Skolnik E.Y., Yang Z., Makita Z., Radoff S., Kirkstein M., Vlassar H. Human and Rat Mesangial Cell Receptors for Glucose-Modified Proteins Potential Role in Kidney Tissue Remodeling and Diabetic Nephropathy. J. Exp. Med. 174:1991;931-939.
12. Ritz E., Deppisch R., Nawroth P. Toxicity of Uraemia Does it Come of AGE? Nephrol. Diel. Transplant. 9:1994;1-2.
13. Korbert S.M., Makita Z., Firanek C.A., Vlassara H. Advanced Glycolsylation End Products in Continuous Ambulatory Peritoneal Dialysis Patients. Am. J. Kidney Dis. 22:1993;588-591.
14. Gugliucci A., Bendayan M. Renal Fate of Circulating Advanced Glycation End Products (AGE) Evidence for Reabsorption and Catabolism of AGE-Peptides by Renal Proximal Tubular Cells. Diabetologia. 39:1996;149-160.
15. Lapolla A., Fedele D., Senesi A., Aricò N.C., Reitano R., Favretto D., Seraglia R., Astner H., Traldi P. Advanced Glycation End Products/Peptides A Preliminary Investigation by LC and LC/MS. Il Farmaco. 57:2002;845-852.
16. Marotta E., Lapolla A., Fedele D., Senesi A., Reitano R., Witt M., Seraglia R., Traldi P. Accurate Mass Measurements by Fourier Transform Mass Spectrometry in the Study of Advanced Glycation End Products/Peptides. J. Mass Spectrom. 38:2003;196-205.
17. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissing H., Shindyalov I.N., Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 28:2000;235-242. ( http://www.rcsb.org/pdb/ ).
18. Schnider S.L., Kohn R.R. Effects of Age and Diabetes Mellitus on the Solubility of Collagen from Human Skin, Tracheal Cartilage, and Dura Mater. Exp. Gerontol. 17:1982;185-194.
19. March R.E., Todd J.F.J. Practical Aspects of Ion Trap Mass Spectrometry. Vols. I and II:1995;CRC Press, Boca Raton, FL.
20. Jeno P., Mini T., Moes S., Hintermann E., Horst M. Internal Sequences from Protein Digested in Polyacrylamide Gels. Anal. Biochem. 224:1995;75-82.
21. Perides G., Kuhn S., Scherbarth A., Traub P. Probing of Structural Stability of Vimentin and Desmin-Type Intermediate Filaments with Calcium Activated Proteinase, Thrombin, and Lysine-Specific Endoproteinase Lys-C. Eur. J. Cell Biol. 43:1987;450-458.
22. Garlick R.L., Mazer J.S. The Principal Site of Nonenzymatic Glycosylation of Human Serum Albumin In Vivo. J. Biol. Chem. 258:1983;6142-6146.
23. Day J.F., Thorpe S.R., Baynes J.W. Nonenzymatically Glycosylated Albumin. J. Biol. Chem. 254:1979;595-597.
24. Iberg N., Fluckiger R. Nonenzymatic Glycosylation of Albumin in Vivo. J. Biol. Chem. 261:1986;13542-13545.